The Sandoz Family Foundation is the investment and philanthropic vehicle of the Sandoz family of Switzerland, whose wealth traces to the founding family of Sandoz pharmaceutical company. The Sandoz company merged with Ciba-Geigy in 1996 to form Novartis, one of the world’s largest pharmaceutical companies. The family foundation manages approximately $5 billion in assets from its base in Lausanne.
Investment Strategy
The Sandoz Family Foundation maintains a diversified investment portfolio spanning public equities, fixed income, private equity, venture capital, and real estate. The foundation’s investment approach balances financial returns with the preservation of capital to support its philanthropic activities in arts, culture, and education.
The foundation’s private markets program includes commitments to European and global fund managers across buyout, growth equity, and venture capital strategies. The family’s pharmaceutical heritage provides institutional knowledge in healthcare and life sciences, though the investment portfolio extends well beyond these sectors to include technology, consumer, and industrial opportunities.
As a Swiss-based family foundation, the Sandoz Family Foundation benefits from Switzerland’s stable regulatory environment, access to European and global investment opportunities, and proximity to a deep network of family offices and private banks in Geneva and Zurich.
How to Approach
Fund managers approaching the Sandoz Family Foundation should recognize the foundation’s Swiss heritage and European orientation. Managers with strategies in European buyout, growth equity, venture capital, or healthcare may find natural alignment. The foundation values discretion, long-term relationships, and managers who demonstrate both strong financial returns and operational integrity. Engagement through Swiss private banking networks or European family office conferences may be effective channels for initial contact.
Frequently Asked Questions
What is the Sandoz Family Foundation's origin?
The Sandoz Family Foundation was established by descendants of Edouard-Marcel Sandoz, a scion of the family behind Sandoz pharmaceutical company (now part of Novartis). The foundation manages the family's wealth and philanthropic activities from its base in Lausanne, Switzerland, investing in both financial markets and cultural/educational initiatives.
Does the Sandoz Family Foundation invest in healthcare and life sciences?
Given the family's pharmaceutical heritage, the Sandoz Family Foundation maintains interest in healthcare and life sciences investments, though its portfolio is diversified across sectors. The foundation invests in private equity, venture capital, and public market strategies spanning technology, consumer, and industrial sectors alongside healthcare-oriented opportunities.
How does the Sandoz Family Foundation approach fund investments?
The Sandoz Family Foundation maintains LP relationships with select fund managers across private equity, venture capital, and real estate strategies. The foundation's investment team evaluates managers with an emphasis on long-term track records, alignment of interests, and strategies that complement the foundation's broader mission. Swiss and European managers may have a natural advantage in building relationships.
